[{"AccountsPayableCurrent_0_Q3_USD":10167000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":41423000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":72522000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":1386785000.0,"OtherNonoperatingIncome_3_Q3_USD":3806000.0,"OtherNonoperatingIncome_1_Q3_USD":1101000.0,"OtherNoncashIncomeExpense_3_Q3_USD":-9420000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":8086000.0,"OtherLiabilitiesCurrent_0_Q3_USD":268000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-673000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-117000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":-141000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":-14000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":-24000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3_Q3_USD":0.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q3_USD":0.0,"OtherAssetsNoncurrent_0_Q3_USD":4788000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":332000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":175132000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":192734000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":12641000.0,"OperatingIncomeLoss_3_Q3_USD":519226000.0,"OperatingIncomeLoss_1_Q3_USD":-128849000.0,"OperatingExpenses_3_Q3_USD":382838000.0,"OperatingExpenses_1_Q3_USD":129673000.0,"NumberOfOperatingSegments_3_Q3_Segment":1.0,"NonoperatingIncomeExpense_3_Q3_USD":3806000.0,"NonoperatingIncomeExpense_1_Q3_USD":1101000.0,"NetIncomeLoss_3_Q3_USD":518909000.0,"NetIncomeLoss_1_Q3_USD":-127153000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":213267000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3_Q3_USD":31379000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":432593000.0,"ProfitLoss_3_Q3_USD":518909000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":80554682.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":76288534.0,"TreasuryStockValue_0_Q3_USD":63000.0,"TreasuryStockShares_0_Q3_shares":180316.0,"TaxesPayableCurrent_0_Q3_USD":3265000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":8875000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q3_USD":4000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":964436.0,"StockholdersEquity_0_Q3_USD":2512923000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":136.22,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":33.09,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q3_USD":55.89,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q3_shares":7887772.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":55.89,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":625010000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":7887772.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_3_Q3_USD":65.84,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_3_Q3_shares":379930.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":37.27,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":4374086.0,"ShareBasedCompensation_3_Q3_USD":76622000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":902064000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":824000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-54667000.0,"RestrictedCashNoncurrent_0_Q3_USD":16848000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":304163000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":105321000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":105883000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":138709000.0,"PropertyPlantAndEquipmentFairValueDisclosure_0_Q3_USD":9340000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":1130158.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":76288534.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-1026714000.0,"MarketableSecuritiesCurrent_0_Q3_USD":1465812000.0,"CommonStockValue_0_Q3_USD":2366000.0,"CommonStockSharesOutstanding_0_Q3_shares":76463180.0,"CommonStockSharesIssued_0_Q3_shares":76643496.0,"CommonStockSharesAuthorized_0_Q3_shares":145364335.0,"CommonStockParOrStatedValuePerShare_0_Q3_CHF":0.03,"CommitmentsAndContingencies_0_Q3_USD":null,"CashEquivalentsAtCarryingValue_0_Q3_USD":530477000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-157072000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":1028396000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q3_USD":6784000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":1011548000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":6264000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":1465812000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":1466614000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":956000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":154000.0,"AssetsCurrent_0_Q3_USD":2518935000.0,"Assets_0_Q3_USD":2821725000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":1706783.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":8911688.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":76622000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":26199000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":26199000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":2566057000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-770000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":32826000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":3567000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":68303000.0,"AccountsReceivableNetCurrent_0_Q3_USD":152000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-127294000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":518222000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":1562000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":11776000.0,"MarketableSecurities_0_Q3_USD":481100000.0,"LiabilitiesCurrent_0_Q3_USD":96206000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":2821725000.0,"Liabilities_0_Q3_USD":308802000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":18775000.0,"IncreaseDecreaseInOtherOperatingLiabilities_3_Q3_USD":-6483000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-779000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":8000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":14733000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":4123000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":-595000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":523032000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-127748000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":78675000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":244646000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":24352000.0,"FairValueNetAssetLiability_0_Q3_USD":16000000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q3_USD":159200000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":17027000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_Q3_USD":-14000.0,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":0.008,"EffectiveIncomeTaxRateContinuingOperations_1_Q3_pure":0.005,"EarningsPerShareDiluted_3_Q3_USD":6.44,"EarningsPerShareDiluted_1_Q3_USD":-1.67,"EarningsPerShareBasic_3_Q3_USD":6.85,"EarningsPerShareBasic_1_Q3_USD":-1.67,"DepreciationDepletionAndAmortization_3_Q3_USD":11692000.0,"Depreciation_3_Q3_USD":11700000.0,"Depreciation_1_Q3_USD":5300000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q3_USD":1028900000.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":139000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":75712437.0,"Ticker":"CRSP","CIK":"1674416","name":"CRISPR THERAPEUTICS AG","OfficialName":"CRISPR Therapeutics AG Common Shares","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4543904930.0","Country":"Switzerland","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20211103"}]